Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
HIMS Earnings Ahead: Wegovy Offers Upside, Analysts Advise Caution
11:30am, Monday, 05'th May 2025
"There's a sense of caution" heading into Hims & Hers (HIMS) earnings, says Caroline Woods. The telehealth company is up over 65% so far in 2025 but has fallen more than 40% off its February highs.
Hims & Hers brings former Amazon executive into C-suite
10:00am, Monday, 05'th May 2025
Hims & Hers Health announced Nader Kabbani will join the telehealth company as its new chief operations officer. Kabbani spent nearly 20 years at Amazon, where he oversaw the launch of Amazon Pharmacy
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
09:01am, Monday, 05'th May 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Nader Kabbani as Chief Operations Officer.1 A season
Can Sustained Product Demand Drive HIMS Stock Before Q1 Earnings?
12:00pm, Friday, 02'nd May 2025
The continued solid uptake of Hims & Hers offerings and expanding subscriber base are likely to have driven the company's performance in the first quarter of 2025.
Hims & Hers: Revolutionizing Healthcare
11:12am, Thursday, 01'st May 2025
The company's vertically integrated platform enhances scalability and efficiency, controlling the entire patient experience from consultation to medication delivery. Partnerships, especially with Novo
4 MedTech Stocks Poised to Outshine Q1 Earnings Estimates
08:30am, Thursday, 01'st May 2025
MedTech companies' quarterly results are likely to reflect base business recovery on a year-over-year basis. Let's see how HIMS, GMED, QDRL and HAE are poised ahead of their earnings release.
Buy Hims (HIMS) or Novo Nordisk (NVO) Stock After Partnership Announcement?
05:50pm, Wednesday, 30'th Apr 2025
Medical pioneers Hims & Hers Health (HIMS) and Novo Nordisk (NVO) are making headlines this week after announcing a partnership to expand obesity care in the telehealth space.
Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?
01:45pm, Wednesday, 30'th Apr 2025
Both HIMS and TDOC are technology-intensive healthcare companies that leverage their strengths in the digital health space to enhance their platforms. Which one is a better investment?
Live Nasdaq Composite: Markets Stand Still on Tariff and Tech Tussle
12:05pm, Wednesday, 30'th Apr 2025
Live Updates Live Coverage Has Ended Trade Deals 3:06 pm by Gerelyn Terzo Commerce Secretary Howard Lutnick reportedly revealed that the U.S. has secured one trade deal, keeping most of the details cl
Hims & Hers Stock Soars on Novo Nordisk Collaboration
10:39am, Wednesday, 30'th Apr 2025
Every once in a while, investors come across some of the best names in a given industry, which then become subject to the best news and developments during a holding period. Today's best pick seems to
Hims & Hers stock price soars after partnership with Novo Nordisk to offer weight-loss drug Wegovy
09:11am, Wednesday, 30'th Apr 2025
Shares in Hims & Hers Health, Inc. (NYSE: HIMS) are skyrocketing in early-morning trading today after the telehealth company announced a new partnership with the Danish pharmaceutical giant Novo Nordi
Hims & Hers Health (HIMS) Stock Jumps 23.0%: Will It Continue to Soar?
06:35am, Wednesday, 30'th Apr 2025
Hims & Hers Health (HIMS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near te
S&P 500 (VOO) Live: Trump Administration Blasts Amazon.com, and the S&P 500 Tumbles
04:32pm, Tuesday, 29'th Apr 2025
Live Updates Live Coverage Has Ended S&P 500 Extends Its Winning Streak 4:18 pm The S&P 500 closed up 0.6% for Tuesday, extending its winning streak to six straight days. Trade Talks Keep S&am
Hims & Hers Health: GLP-1 Deals De-Risk The Story
03:27pm, Tuesday, 29'th Apr 2025
Hims & Hers Health partners with Novo Nordisk to offer Wegovy, de-risking investment but not significantly altering the business focus on personalized healthcare solutions. The health and wellness pla
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
03:19pm, Tuesday, 29'th Apr 2025
Shares of Hims & Hers Health (HIMS 25.46%) and LifeMD (LFMD 35.41%) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m.
